Search Results for "ONS on call"

Because of weakened immune systems and prolonged treatment courses, patients with cancer have a higher chance of developing sepsis. Once acquired, sepsis puts patients at risk for hospitalization and increased morbidity and mortality. Prevention and prompt management are essential to improve outcomes. 

Radium 223 dichloride (Xofigo^®) is an alpha particle-emitting radioactive therapeutic agent approved by the U.S. Food and Drug Administration in 2013 for castrate-resistant prostate cancer.

ONS member Roberta Kaplow, RN, PhD, CCRN, AOCNS^®, clinical nurse specialist at Emory University Hospital in Atlanta, GA, and member of the Metro Atlanta ONS Chapter, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about the latest nursing management and prevention strategies for malignant pleural effusion.

Elevated intracranial pressure is a life-threatening cancer complication, but oncology nurses can take steps to prevent and recognize it in their patients. ONS member Mary Elizabeth Davis, DNP, RN, AOCNS^®, clinical nurse specialist at Memorial Sloan Kettering Cancer Center in New York, NY, and member of the New York City ONS Chapter, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about the latest nursing strategies for increased intracranial pressure, a situation that can occur with a brain tumor, abscess, infection, or other conditions that increases or obstructs cerebrospinal fluid or blood flow in the brain. This episode is part of a series about oncologic emergencies; the previous episodes are linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes. 

ONS member Susan Bruce, MSN, RN, AOCNS^®, clinical nurse specialist at Duke Raleigh Cancer Center in North Carolina and member of the North Carolina Triangle ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss febrile neutropenia and nursing considerations for its management and prevention. This episode is part of an ongoing series about oncologic emergencies; the previous episode is linked in the episode notes. The advertising messages in this episode are brought to you by G1 Therapeutics, Inc. 

The BRAF Biomarker Quick Guide provides an overview for this high-frequency biomarker and illustrates normal and BRAF variant cell-signaling pathways. This guide facilitates understanding of BRAF variant frequency and potential variant therapies. Clinicians can apply this information to practice during patient and family discussions about BRAF biomarkers and targeted therapies. 

ONS member and 2019 Congress Presenter John Hillson, RN, BSN, BA, OCN^®, clinical nurse at Duke Radiation Oncology in Durham, NC, joins Chris Pirschel, ONS staff writer, to discuss managing radiation side effects for patients with head and neck cancers, helping patients navigate the complexities of radiation therapy, and supporting patients throughout the cancer journey.

Watch this ONS video on cytokine release syndrome with CAR T-cell therapy.